Director of Alternative Investments
Bei Saville is the Director of Alternative Investments at the Helmsley Charitable Trust. She is part of the development and implementation of the overall investment strategy for the Trust and is principally responsible for the deployment and management of the Trust's investments in alternative asset classes such as private equity, venture capital, hedge funds and real assets.
Prior to joining the Trust, Ms. Saville managed the alternatives portfolio at Pfizer, where she was also responsible for Pfizer’s DC plans and asset/liability research. Prior to Pfizer, Ms. Saville was a vice president in Morgan Stanley’s Global Portfolio Solutions group, where she designed and managed alternatives portfolios and advised on asset allocation decisions for large institutional investors. Prior to that, she held strategic planning and finance roles at Morgan Stanley, JPMorgan and David J. Greene. Ms. Saville began her career in real estate development with China National Real Estate Development Group, the largest real estate developer in China.
Ms. Saville received an MBA with honors from Old Dominion University and a B.S. from the Renmin University of China. She also holds the CFA and CAIA designations, and has served on multiple advisory boards of private equity, venture capital and real estate funds.